To date Accord South Africa has successfully leveraged off the immense technological capabilities within our multinational group, both in R&D and high quality modern manufacturing, to bring affordable and bioequivalent generics with impeccable international credentials to the South African patient and healthcare practitioner. In the future, the Accord South Africa team is committed to maintaining the highest international standards of quality in the design, manufacture and supply of generic medication to all South Africans and is deeply invested in contributing to the improvement of medical care for all South Africans.
Key Oncologics (Pty) Ltd is a South African pharmaceutical company that primarily focuses on the treatment of cancer and allied diseases. Key Oncologics was founded in 1998 representing international companies that do not have an independent presence in South Africa. Over the years, the company’s product profile has grown from a single product to a comprehensive portfolio. The company has also diversified into biologics and is in the process of building a generic portfolio. In moving forward Key Oncologics will continue to seek options for patients to live longer and live better.
39 11th Avenue
Tel: +27 11 483 0060
Fax: +27 11 728 5060